Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1356 studies found for:    "Genital Diseases, Female" | United States
Show Display Options
Rank Status Study
1 Unknown  Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Conditions: Endometrial Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Leiomyoma
Intervention:
2 Unknown  LANDA Embryo Freezing Technique.
Conditions: Primary Infertility;   Secondary Infertility;   Genital Diseases, Male;   Genital Diseases, Female
Intervention:
3 Completed Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
Conditions: Women's Health;   HIV Infection;   Genital Diseases, Female
Intervention:
4 Recruiting Prognostic Markers of Gynecologic Cancers
Conditions: Gynecologic Disease;   Gynecologic Cancer
Intervention:
5 Active, not recruiting Novel Topical Therapies for the Treatment of Genital Pain
Condition: Female Genital Diseases
Interventions: Drug: Amitriptyline;   Drug: Baclofen;   Drug: Ketoprofen;   Drug: Ketamine;   Drug: Loperamide;   Drug: Gabapentin;   Drug: placebo
6 Recruiting Biomarkers for Gynecologic Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Benign Gynecological Disease
Intervention:
7 Completed A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Conditions: Solid Tumors and Advanced Endometrial Cancer;   Endometrial Cancer;   Second-line Treatment;   VEGF
Intervention: Drug: TKI258
8 Not yet recruiting Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients
Conditions: Laparotomy;   Gynecologic Diseases
Intervention: Other: Enhanced recovery protocol
9 Withdrawn Laparoscopic Supracervical Hysterectomy Versus Total Laparoscopic Hysterectomy
Condition: Gynecologic Diseases
Interventions: Procedure: Laparoscopic supracervical hysterectomy;   Procedure: Total laparoscopic hysterectomy
10 Completed
Has Results
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
Conditions: Esophageal Diseases;   Gastrointestinal Diseases;   Disorder of the Genitourinary System;   Gynecologic Diseases;   Kidney Diseases;   Liver Diseases;   Pancreatic Diseases;   Prostate Cancer;   Spinal Disease
Interventions: Device: Vigileo Monitor;   Device: FloTrac Sensor
11 Terminated Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Condition: Cervical Cancer
Intervention: Drug: gemcitabine hydrochloride
12 Terminated Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride
13 Recruiting A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Condition: Recurrent Vulvovaginal Candidiasis
Interventions: Drug: VT-1161;   Drug: Placebo
14 Completed S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: pegylated liposomal doxorubicin hydrochloride
15 Unknown  Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Conditions: Chemotherapeutic Agent Toxicity;   Fallopian Tube Cancer;   Neurotoxicity;   Ovarian Cancer;   Pain;   Peripheral Neuropathy;   Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: glutathione;   Drug: paclitaxel;   Other: placebo
16 Active, not recruiting Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Conditions: Lymphedema;   Stage IA Cervical Cancer;   Stage IA Uterine Corpus Cancer;   Stage IA Vulvar Cancer;   Stage IB Cervical Cancer;   Stage IB Uterine Corpus Cancer;   Stage IB Vulvar Cancer;   Stage II Uterine Corpus Cancer;   Stage II Vulvar Cancer;   Stage IIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVB Vulvar Cancer
Interventions: Procedure: Therapeutic Lymphadenectomy;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Laparoscopic Surgery;   Procedure: Study of High Risk Factors;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment
17 Recruiting A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Condition: Endometriosis
Interventions: Drug: Elagolix;   Other: placebo
18 Recruiting Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Gastrointestinal Complications;   Perioperative/Postoperative Complications;   Radiation Toxicity;   Urinary Complications;   Urinary Tract Toxicity
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
19 Active, not recruiting Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer
Conditions: Ovarian Clear Cell Adenocarcinoma;   Recurrent Ovarian Carcinoma
Interventions: Drug: Sunitinib Malate;   Other: Laboratory Biomarker Analysis
20 Active, not recruiting Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Conditions: Heavy Uterine Bleeding;   Uterine Fibroids
Interventions: Other: Placebo;   Drug: Elagolix;   Drug: Estradiol/norethindrone acetate, E2/NETA;   Drug: Estradiol/norethindrone acetate, E2/NETA Dose 2;   Drug: Estradiol/norethindrone acetate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years